UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 743

Sortiert nach

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

PloS one, 2016-06, Vol.11 (6), p.e0157160-e0157160

2016

Volltextzugriff (PDF)

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Neurology, 2010-12, Vol.75 (23), p.2087

2010

Volltextzugriff (PDF)

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects

Clinical infectious diseases, 2014-10, Vol.59 (7), p.1032-1037

2014

Volltextzugriff (PDF)

Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV

International journal of molecular sciences, 2023-02, Vol.24 (3), p.2832

2023

Volltextzugriff (PDF)

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria

PloS one, 2016-02, Vol.11 (2), p.e0147182-e0147182

2016

Volltextzugriff (PDF)

Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations

PLoS pathogens, 2017-01, Vol.13 (1), p.e1006112

2017

Volltextzugriff (PDF)

Elevated Biomarkers of Inflammation and Vascular Dysfunction Are Associated with Distal Sensory Polyneuropathy in People with HIV

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4245

2024

Volltextzugriff (PDF)

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

Neurology, 2012-02, Vol.78 (7), p.485

2012

Volltextzugriff (PDF)

Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid

Clinical infectious diseases, 2020-08, Vol.71 (4), p.982-988

2020

Volltextzugriff (PDF)

Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder

Journal of the International Neuropsychological Society, 2024-01, Vol.30 (1), p.84-93

2024

Volltextzugriff (PDF)

EDITORIAL COMMENTARY: Protease Inhibitor Monotherapy: Safe for the CNS in Durably Suppressed Patients?

Clinical infectious diseases, 2014-12, Vol.59 (11), p.1635-1637

Letendre, Scott L.

2014

Volltextzugriff (PDF)

Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs

Viruses, 2023-08, Vol.15 (8), p.1712

2023

Volltextzugriff (PDF)

Effects of Opioid Withdrawal on Psychobiology in People Living with HIV

Viruses, 2024-01, Vol.16 (1), p.92

2024

Volltextzugriff (PDF)

Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV

Viruses, 2023-08, Vol.15 (9), p.1835

2023

Volltextzugriff (PDF)

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

AIDS (London), 2009-05, Vol.23 (8), p.907-915

2009

Volltextzugriff (PDF)

Reply to Augello, P.A.; Wu, J. Comment on "Rogers et al. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. Viruses 2023, 15 , 674"

Viruses, 2023-09, Vol.15 (9), p.1878

2023

Volltextzugriff (PDF)

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition

Viruses, 2023-03, Vol.15 (3), p.674

2023

Volltextzugriff (PDF)

Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort

PloS one, 2012-11, Vol.7 (11), p.e47310-e47310

2012

Volltextzugriff (PDF)

Elevated Plasma Protein Carbonyl Concentration Is Associated with More Abnormal White Matter in People with HIV

Viruses, 2023-12, Vol.15 (12), p.2410

2023

Volltextzugriff (PDF)

Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop

AIDS research and human retroviruses, 2023-01, Vol.39 (1), p.1

2023

Volltextzugriff (PDF)

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

Annals of neurology, 2004-09, Vol.56 (3), p.416-423

2004

Volltextzugriff (PDF)

A Haptoglobin Exon Copy Number Variant Associates With HIV-Associated Neurocognitive Impairment in European and African-Descent Populations

Frontiers in genetics, 2021-12, Vol.12, p.756685-756685

2021

Volltextzugriff (PDF)

The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs

Journal of veterinary pharmacology and therapeutics, 2017-01, Vol.40 (1), p.35-43

2017

Volltextzugriff (PDF)

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

AIDS (London), 2010-04, Vol.24 (7), p.983-990

2010

Volltextzugriff (PDF)

Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV

Brain, behavior, & immunity. Health, 2022-12, Vol.26, p.100560-100560, Article 100560

2022

Volltextzugriff (PDF)

1 – 25 von 743

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(525)
Mit Volltextzugriff
(633)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects

Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria

Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations

Elevated Biomarkers of Inflammation and Vascular Dysfunction Are Associated with Distal Sensory Polyneuropathy in People with HIV

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid

Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder

EDITORIAL COMMENTARY: Protease Inhibitor Monotherapy: Safe for the CNS in Durably Suppressed Patients?

Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs

Effects of Opioid Withdrawal on Psychobiology in People Living with HIV

Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

Reply to Augello, P.A.; Wu, J. Comment on "Rogers et al. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. Viruses 2023, 15 , 674"

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition

Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort

Elevated Plasma Protein Carbonyl Concentration Is Associated with More Abnormal White Matter in People with HIV

Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

A Haptoglobin Exon Copy Number Variant Associates With HIV-Associated Neurocognitive Impairment in European and African-Descent Populations

The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV

Suchergebnisse filtern